A new tool to assess Clinical Diversity In Meta-analyses (CDIM) of interventions
Autor: | De Zhao Kong, Georgina Imberger, Jørn Wetterslev, Bao-Yong Lai, Geert Koster, Naqash J Sethi, Andreas Bender Jonsson, Steven Kwasi Korang, Rui-Xue Hu, Emilie C Risom, Bente Thoft Jensen, Anders Granholm, Morten Hylander Møller, Maria L. Fabritius, Sanam Safi, Mathias Maagaard, Anders Perner, Meint Volbeda, Susanne Vahr Lauridsen, Anja Geisler, Bart Hiemstra, Nico van Bakelen, Marie Warrer Munch, Ruben J. Eck, Oliver Karam, Eric Keus, Christian Gluud, Barzi Gareb, Emil Eik Nielsen, Søren Marker, A. K. Nørskov, Ning Liang, Thijs M. Koster, Sofie Louise Rygård, Willem Dieperink, Maria Cronhjort, Fredrik Sjövall, Tine Sylvest Meyhoff, Fredrike Blokzijl, Iwan C. C. van der Horst, Marija Barbateskovic, Josh Feinberg, Lars Hyldborg Lundstrøm, Arash Afshari, Craig French |
---|---|
Přispěvatelé: | RS: Carim - V04 Surgical intervention, Intensive Care, MUMC+: MA Medische Staf IC (9), MUMC+: MA Intensive Care (3), Critical care, Anesthesiology, Peri-operative and Emergency medicine (CAPE), Anesthesiology |
Jazyk: | angličtina |
Rok vydání: | 2021 |
Předmět: |
medicine.medical_specialty
Epidemiology Population Psychological intervention Outcome assessment GUIDELINES 03 medical and health sciences 0302 clinical medicine Disease severity Bias Meta-Analysis as Topic medicine Humans HETEROGENEITY 030212 general & internal medicine education Reliability (statistics) Evidence RISK Diversity education.field_of_study business.industry Reproducibility of Results Quality Meta-analysis Research Design AGREEMENT Family medicine Scale (social sciences) RELIABILITY Research Design/statistics & numerical data Systematic review Tool Heterogeneity business human activities 030217 neurology & neurosurgery REVIEWS Diversity (business) |
Zdroj: | Journal of Clinical Epidemiology, 135, 29-41. Elsevier Science Journal of Clinical Epidemiology, 135, 29-41. ELSEVIER SCIENCE INC Barbateskovic, M, Koster, T M, Eck, R J, Maagaard, M, Afshari, A, Blokzijl, F, Cronhjort, M, Dieperink, W, Fabritius, M L, Feinberg, J, French, C, Gareb, B, Geisler, A, Granholm, A, Hiemstra, B, Hu, R, Imberger, G, Jensen, B T, Jonsson, A B, Karam, O, Kong, D Z, Korang, S K, Koster, G, Lai, B, Liang, N, Lundstrøm, L H, Marker, S, Meyhoff, T S, Nielsen, E E, Nørskov, A K, Munch, M W, Risom, E C, Rygård, S L, Safi, S, Sethi, N, Sjövall, F, Lauridsen, S V, van Bakelen, N, Volbeda, M, van der Horst, I C C, Gluud, C, Perner, A, Møller, M H, Keus, E & Wetterslev, J 2021, ' A new tool to assess Clinical Diversity In Meta-analyses (CDIM) of interventions ', Journal of Clinical Epidemiology, vol. 135, pp. 29-41 . https://doi.org/10.1016/j.jclinepi.2021.01.023 Journal of Clinical Epidemiology, 135, 29-41. Elsevier USA |
ISSN: | 0895-4356 |
DOI: | 10.1016/j.jclinepi.2021.01.023 |
Popis: | Objective: To develop and validate Clinical Diversity In Meta-analyses (CDIM), a new tool for assessing clinical diversity between trials in meta-analyses of interventions. Study design and setting: The development of CDIM was based on consensus work informed by empirical literature and expertise. We drafted the CDIM tool, refined it, and validated CDIM for interrater scale reliability and agreement in three groups. Results: CDIM measures clinical diversity on a scale that includes four domains with 11 items overall: setting (time of conduct/country development status/units type); population (age, sex, patient inclusion criteria/baseline disease severity, comorbidities); interventions (intervention intensity/strength/duration of intervention, timing, control intervention, cointerventions); and outcome (definition of outcome, timing of outcome assessment). The CDIM is completed in two steps: first two authors independently assess clinical diversity in the four domains. Second, after agreeing upon scores of individual items a consensus score is achieved. Interrater scale reliability and agreement ranged from moderate to almost perfect depending on the type of raters. Conclusion: CDIM is the first tool developed for assessing clinical diversity in meta-analyses of interventions. We found CDIM to be a reliable tool for assessing clinical diversity among trials in meta-analysis. (c) 2021 Elsevier Inc. All rights reserved. |
Databáze: | OpenAIRE |
Externí odkaz: |